The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(Z)-6-[(1R,2S)-2-Azepan-1-yl-5-(2'-hydroxy-biphenyl-4-ylmethoxy)-cyclopentyloxy]-hex-4-enoic acid ID: ALA350286
PubChem CID: 44374693
Max Phase: Preclinical
Molecular Formula: C30H39NO5
Molecular Weight: 493.64
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3O)cc2)CC[C@@H]1N1CCCCCC1
Standard InChI: InChI=1S/C30H39NO5/c32-27-11-6-5-10-25(27)24-15-13-23(14-16-24)22-36-28-18-17-26(31-19-7-1-2-8-20-31)30(28)35-21-9-3-4-12-29(33)34/h3,5-6,9-11,13-16,26,28,30,32H,1-2,4,7-8,12,17-22H2,(H,33,34)/b9-3-/t26-,28?,30+/m0/s1
Standard InChI Key: XDBBQUBSMKTSDO-DNNNXZGLSA-N
Molfile:
RDKit 2D
36 39 0 0 1 0 0 0 0 0999 V2000
1.4667 -3.2542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2875 -2.4542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0542 -3.8417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.7625 -3.6792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7167 -0.8750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4667 -2.3792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9000 -0.9000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2417 -3.2417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0417 -1.6667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.1167 -0.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1417 -3.1375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9042 -2.9750 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.4875 -0.1917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5000 -1.6167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3792 -2.4042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2417 -2.4667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0792 -2.2375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.4417 -0.9542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2667 -0.9417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1417 -3.9500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.6667 -0.2167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6792 -1.6375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6875 0.5458 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.7875 -4.6167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8250 -3.5667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6667 -2.8167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1250 -1.5792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6792 -2.8042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7417 -3.0542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9292 -0.1417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2250 -5.3125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5250 -4.0042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9417 -1.5667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3417 -0.8417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0417 -5.3917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6250 -4.8167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
1 3 1 1
4 1 1 0
5 7 1 0
6 2 1 0
7 14 1 0
8 28 1 0
9 6 1 0
10 5 1 0
11 4 1 0
12 8 2 0
13 21 1 0
14 22 2 0
15 26 1 0
16 15 2 0
2 17 1 6
18 9 1 0
19 18 1 0
20 8 1 0
21 19 2 0
22 19 1 0
23 10 1 0
24 3 1 0
25 3 1 0
26 17 1 0
27 5 2 0
28 29 1 0
29 16 1 0
30 10 2 0
31 24 1 0
32 25 1 0
33 27 1 0
34 33 2 0
35 31 1 0
36 32 1 0
6 11 1 0
36 35 1 0
7 13 2 0
34 30 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 493.64Molecular Weight (Monoisotopic): 493.2828AlogP: 5.79#Rotatable Bonds: 11Polar Surface Area: 79.23Molecular Species: ZWITTERIONHBA: 5HBD: 2#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 3.79CX Basic pKa: 10.26CX LogP: 3.00CX LogD: 3.00Aromatic Rings: 2Heavy Atoms: 36QED Weighted: 0.39Np Likeness Score: 0.79
References 1. Campbell I, Collington E, Finch H, Hallett P, Hayes R, Lumley P, Mills K, Wallis C, White B. (1991) Synthesis and pharmacological evaluation of novel Amino-prostanoids: potent and orally effective thromboxane A2 receptor antagonists, 1 (12): [10.1016/S0960-894X(01)81049-0 ]